FDA Approves Non-Invasive CRC Screening Test for Eligible Individuals Ages 45 to 49

Exact Sciences Corp. announced September 23 that the U.S. Food and Drug Administration (FDA) has approved the company's non-invasive colorectal cancer (CRC) screening test, Cologuard, for eligible average-risk individuals ages 45 and older, expanding on its previous indication for ages 50 and older.

Read corporate press release.

Posted 9/24/2019